Century names CFO, CSO

Century Therapeutics Inc. (NASDAQ:IPSC) named Morgan Conn CFO and Chad Cowan CSO, as the iPSC company advances its pipeline and expands into additional autoimmune indications. Conn, whose appointment is effective Oct. 14, was CBO at Pharvaris N.V. (NASDAQ:PHVS). Cowan, who starts on Oct. 1, founded and was CEO of Clade Therapeutics Inc., which Century acquired in April. 

Century added that President of R&D Hy Levitsky will become an adviser...